Hallmarks of Alzheimer disease are evolving relentlessly in Metropolitan Mexico City infants, children and young adults. APOE4 carriers have higher suicide risk and higher odds of reaching NFT stage V at <=40 years of age
Exposures to fine particulate matter (PM2.5) and ozone (O3) above USEPA standards are associated with Alzheimer's disease (AD) risk. Metropolitan Mexico City (MMC) residents have life time exposures to PM2.5 and O3 above USEPA...[more]
15.04.2018
Contrast agents containing gadolinium: Deposits in the brain and other tissues
The Federal Institute for Drugs and Medical Devices (BfArM) issues information on the realisation of the EU Commission's implementing decision following the European Medicines Agency's (EMA) scientific review of contrast agents...[more]
30.03.2018
New Newsletter N° 23 - March 2018 Now Online
Topics: Laboratory News, Organic Environmental Pollutants / Environmental Pollutants, Commonly used Environmental pollutants, Fluoride, Formaldehyde, Polychlorinated Biphenyl (PCB), Polycyclic Aromatic Hydrocarbons (PAH),...[more]
18.03.2018
Category: Newsletter
Proven vaginal high-dose vitamin D3 recipes
Prof. Dr. med. Claus Schulte-Uebbing, Prof. Dr. med. Ingrid Gerhard and Doru Ioan Craiut present proven vaginal high-dose vitamin D3 recipes for gynecological, urological and oncological practice. New small studies have shown,...[more]
17.03.2018
Baby teeth link autism and heavy metals, NIH study suggests
Baby teeth from children with autism contain more toxic lead and less of the essential nutrients zinc and manganese, compared to teeth from children without autism, according to an innovative study funded by the National...[more]
25.02.2018
Air Pollution and Alzheimer Disease
Is poor air quality involved in the pathogenesis of Alzheimer's disease? German and Dutch scientists joint for a project that is trying to find an answer, informs the non-profit Alzheimer Research Initiative (AFI). The research...[more]
09.02.2018
Gadolinium-containing contrasting agents
The German Medical Association (AkdÄ) Drug Commission sent out information on the intravenous use of gadolinium-containing contrasting agents. In cooperation with the European Medicines Agency (EMA) and The German Institute...[more]
30.01.2018